High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells

Journal of Experimental Medicine

Volumn 204, Issue 10, 2007, Pages 2383-2396

  Miyagi, Takuya ^a   Gil, M Pilar ^a   Wang, Xin ^a   Louten, Jennifer ^a   Chu, Wen Ming ^a   Biron, Christine A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON RECEPTOR; STAT1 PROTEIN; STAT2 PROTEIN; STAT4 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; GENE EXPRESSION REGULATION; INTERFERON TYPE I; INTERFERON TYPE II; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; RECEPTOR, INTERFERON ALPHA-BETA; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR;

EID: 34948870247     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070401     Document Type: Article

References (60)

1. Biron, C.A., and G.C. Sen. 2007. Innate immune responses to viral infection. In Fields Virology. Fifth Edition. D.M. Knipe and P.M. Howley, editors. Walter Kluwer/Lippincott, Williams & Wilkins, Philadelphia. 249-278 pp.
2. Farrar, M.A., and R.D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571-611.
3. Garcia-Sastre, A., and C.A. Biron. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science. 312:879-882.
4. Levy, D.E., and J.E. Darnell Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3:651-662.
5. Platanias, L.C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5:375-386.
6. Stark, G.R., I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
7. Gupta, S., H. Yan, L.H. Wong, S. Ralph, J. Krolewski, and C. Schindler. 1996. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals. EMBO J. 15:1075-1084.
8. Yan, H., K. Krishnan, A.C. Greenlund, S. Gupta, J.T. Lim, R.D. Schreiber, C.W. Schindler, and J.J. Krolewski. 1996. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J. 15:1064-1074.
9. Brierley, M.M., and E.N. Fish. 2002. Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J. Interferon Cytokine Res. 22:835-845.
10. Nguyen, K.B., W.T. Watford, R. Salomon, S.R. Hofmann, G.C. Pien, A. Morinobu, M. Gadina, J.J. O ' Shea, and C.A. Biron. 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science. 297:2063-2066.
11. Biron, C.A., K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220.
12. Orange, J.S., and C.A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138-1142.
13. Nguyen, K.B., L.P. Cousens, L.A. Doughty, G.C. Pien, J.E. Durbin, and C.A. Biron. 2000. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat. Immunol. 1:70-76.
14. Thierfelder, W.E., J.M. van Deursen, K. Yamamoto, R.A. Tripp, S.R. Sarawar, R.T. Carson, M.Y. Sangster, D.A. Vignali, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 382:171-174.
15. Nguyen, K.B., T.P. Salazar-Mather, M.Y. Dalod, J.B. Van Deusen, X.Q. Wei, F.Y. Liew, M.A. Caligiuri, J.E. Durbin, and C.A. Biron. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279-4287.
16. Rogge, L., D. D'Ambrosio, M. Biffi, G. Penna, L.J. Minetti, D.H. Presky, L. Adorini, and F. Sinigaglia. 1998. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 161:6567-6574.
17. Cho, S.S., C.M. Bacon, C. Sudarshan, R.C. Rees, D. Finbloom, R. Pine, and J.J. O ' Shea. 1996. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 157:4781-4789.
18. Berenson, L.S., M. Gavrieli, J.D. Farrar, T.L. Murphy, and K.M. Murphy. 2006. Distinct characteristics of murine STAT4 activation in response to IL-12 and IFN-alpha. J. Immunol. 177:5195-5203.
19. Wang, J., N. Pham-Mitchell, C. Schindler, and I.L. Campbell. 2003. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain. J. Clin. Invest. 112:535-543.
20. Freudenberg, M.A., T. Merlin, C. Kalis, Y. Chvatchko, H. Stubig, and C. Galanos. 2002. Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling. J. Immunol. 169:1665-1668.
21. Heinzel, F.P. 1990. The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol. 145:2920-2924.
22. Ozmen, L., M. Pericin, J. Hakimi, R.A. Chizzonite, M. Wysocka, G. Trinchieri, M. Gately, and G. Garotta. 1994. Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180:907-915.
23. Billiau, A., H. Heremans, F. Vandekerckhove, and C. Dillen. 1987. Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction. Eur. J. Immunol. 17:1851-1854.
24. Doherty, G.M., J.R. Lange, H.N. Langstein, H.R. Alexander, C.M. Buresh, and J.A. Norton. 1992. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J. Immunol. 149:1666-1670.
25. Car, B.D., V.M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437-1444.
26. Pien, G.C., K.B. Nguyen, L. Malmgaard, A.R. Satoskar, and C.A. Biron. 2002. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J. Immunol. 169:5827-5837.
27. Oldstone, M.B. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263:83-117.
28. Dalod, M., T.P. Salazar-Mather, L. Malmgaard, C. Lewis, C. Asselin-Paturel, F. Briere, G. Trinchieri, and C.A. Biron. 2002. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517-528.
29. Louten, J., N. van Rooijen, and C.A. Biron. 2006. Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection. J. Immunol. 177:3266-3272.
30. Der, S.D., A. Zhou, B.R. Williams, and R.H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA. 95:15623-15628.
31. Pien, G.C., and C.A. Biron. 2000. Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection. J. Immunol. 164:994-1001.
32. Mitani, Y., A. Takaoka, S.H. Kim, Y. Kato, T. Yokochi, N. Tanaka, and T. Taniguchi. 2001. Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells. 6:631-640.
33. Sheehan, K.C., K.S. Lai, G.P. Dunn, A.T. Bruce, M.S. Diamond, J.D. Heutel, C. Dungo-Arthur, J.A. Carrero, J.M. White, P.J. Hertzog, and R.D. Schreiber. 2006. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26:804-819.
34. Gil, M.P., R. Salomon, J. Louten, and C.A. Biron. 2006. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood. 107:987-993.
35. Frucht, D.M., M. Aringer, J. Galon, C. Danning, M. Brown, S. Fan, M. Centola, C.Y. Wu, N. Yamada, H. El Gabalawy, and J.J. O'Shea. 2000. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 164:4659-4664.
36. Longman, R.S., D. Braun, S. Pellegrini, C.M. Rice, R.B. Darnell, and M.L. Albert. 2007. Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood. 109:1113-1122.
37. Lee, C.K., D.T. Rao, R. Gertner, R. Gimeno, A.B. Frey, and D.E. Levy. 2000. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165:3571-3577.
38. Dalod, M., T. Hamilton, R. Salomon, T.P. Salazar-Mather, S.C. Henry, J.D. Hamilton, and C.A. Biron. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J. Exp. Med. 197:885-898.
39. Qing, Y., and G.R. Stark. 2004. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J. Biol. Chem. 279:41679-41685.
40. Alexander, W.S., and D.J. Hilton. 2004. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22:503-529.
41. Fenner, J.E., R. Starr, A.L. Cornish, J.G. Zhang, D. Metcalf, R.D. Schreiber, K. Sheehan, D.J. Hilton, W.S. Alexander, and P.J. Hertzog. 2006. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 7:33-39.
42. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7:454-465.
43. Park, C., S. Li, E. Cha, and C. Schindler. 2000. Immune response in Stat2 knockout mice. Immunity. 13:795-804.
44. Gil, M.P., E. Bohn, A.K. O ' Guin, C.V. Ramana, B. Levine, G.R. Stark, H.W. Virgin, and R.D. Schreiber. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA. 98:6680-6685.
45. Ramana, C.V., M.P. Gil, R.D. Schreiber, and G.R. Stark. 2002. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol. 23:96-101.
46. Lawless, V.A., S. Zhang, O.N. Ozes, H.A. Bruns, I. Oldham, T. Hoey, M.J. Grusby, and M.H. Kaplan. 2000. Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways. J. Immunol. 165:6803-6808.
47. Kaplan, M.H., Y.L. Sun, T. Hoey, and M.J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:174-177.
48. Muller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921.
49. van den Broek, M.F., U. Muller, S. Huang, M. Aguet, and R.M. Zinkernagel. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792-4796.
50. Meraz, M.A., J.M. White, K.C. Sheehan, E.A. Bach, S.J. Rodig, A.S. Dighe, D.H. Kaplan, J.K. Riley, A.C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:431-442.
51. Durbin, J.E., R. Hackenmiller, M.C. Simon, and D.E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84:443-450.
52. Dunn, G.P., A.T. Bruce, K.C. Sheehan, V. Shankaran, R. Uppaluri, J.D. Bui, M.S. Diamond, C.M. Koebel, C. Arthur, J.M. White, and R.D. Schreiber. 2005. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 6:722-729.
53. Orange, J.S., B. Wang, C. Terhorst, and C.A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
54. Salazar-Mather, T.P., J.S. Orange, and C.A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187:1-14
55. Cousens, L.P., J.S. Orange, H.C. Su, and C.A. Biron. 1997. Interferon-alpha/ beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA. 94:634-639.
56. Uzel, G., D.M. Frucht, T.A. Fleisher, and S.M. Holland. 2001. Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin. Immunol. 100:270-276.
57. Krutzik, P.O., M.R. Clutter, and G.P. Nolan. 2005. Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J. Immunol. 175:2357-2365.
58. Dragoi, A.M., X. Fu, S. Ivanov, P. Zhang, L. Sheng, D. Wu, G.C. Li, and W.M. Chu. 2005. DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. EMBO J. 24:779-789.
59. Wang, X., S.M. Huong, M.L. Chiu, N. Raab-Traub, and E.S. Huang. 2003. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature. 424:456-461.
60. Malmgaard, L., T.P. Salazar-Mather, C.A. Lewis, and C.A. Biron. 2002. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways. J. Virol. 76:4520-4525.